What Is Thymosin Alpha-1?
Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide originally isolated from thymosin fraction 5 — a partially purified calf thymus extract. It is the N-terminally acetylated form of a peptide derived from the prothymosin alpha precursor protein and is produced naturally by thymic epithelial cells. Thymosin Alpha-1 has been studied extensively in immunological research and has investigational and approved uses in select jurisdictions outside Canada and the United States, primarily in the context of certain chronic viral infections and as an immunological adjuvant in experimental oncology settings.
As a research compound in Canada, Thymosin Alpha-1 is supplied by TrueCanPeptides for qualified laboratory and preclinical investigational use. It is not approved by Health Canada for therapeutic use.
Mechanism of Action — Research Context
In preclinical and early-phase research, Thymosin Alpha-1 has been studied for its interactions with innate and adaptive immune system pathways. It is thought to act partly through Toll-like receptor (TLR) signalling, particularly TLR2 and TLR9, which are pattern recognition receptors involved in innate immune activation. Research has also examined Tα1 in relation to T-cell maturation, dendritic cell function, and cytokine modulation in controlled experimental settings.
The compound has a well-characterised safety profile in the research literature relative to many immunological peptides, which contributes to its use as a tool compound in immune biology experiments. All mechanistic references here derive from preclinical and investigational literature.
Research Applications
- Immune biology research: Thymosin Alpha-1 is widely studied as a modulator of T-cell and dendritic cell function in controlled immunology experiments.
- TLR signalling studies: Researchers use Tα1 to investigate Toll-like receptor pathway activation and innate immune responses in in vitro and animal models.
- Infectious disease models: Preclinical investigations have studied Thymosin Alpha-1 in viral and bacterial infection models, examining immune response modulation.
- Oncology research (experimental): Early research has examined Tα1 in combination protocols within experimental tumour immunology models.
- Vaccine adjuvant research: Thymosin Alpha-1 has been investigated as a potential adjuvant component in experimental vaccine models, studied for its ability to enhance antigen-specific immune responses.
View Thymosin Alpha-1 5mg — Research Grade
Storage & Handling
Thymosin Alpha-1 should be stored and handled using standard research-grade peptide protocols:
- Store lyophilised peptide at −20°C in sealed containers, protected from moisture and light
- Reconstitute using sterile bacteriostatic water or appropriate buffer according to your research protocol
- Reconstituted solution should be refrigerated at 4°C and used within the timeframe specified by your laboratory SOP
- Do not expose to repeated freeze-thaw cycles; aliquot as needed for multi-use experiments
For more detail, consult our Peptide Storage Guide. Purity and certificate of analysis information is provided on our Quality & Purity page.
Related Research
Thymosin Alpha-1 belongs to the thymosin family of immunologically active peptides, which includes thymosin Beta-4 and thymalin. Researchers investigating immune-modulation themes may also review literature on LL-37, a host defence peptide with overlapping immune biology themes, and general antimicrobial peptide research. For immune-endocrine interface research, Thymosin Alpha-1 is sometimes studied alongside thymic hormones and neuropeptides.
Browse the Research Hub for additional compound overviews or read What Are Peptides? for foundational context.
⚠️ Research Use Only: All content on this page is intended strictly for educational and informational purposes. This compound is not approved by Health Canada or any regulatory agency for human therapeutic use. TrueCanPeptides supplies research-grade compounds to qualified researchers only. This is not medical advice. Do not use any information here for self-administration, diagnosis, or treatment. Consult a licensed healthcare professional for any medical concerns.
See also: What is LL-37?